−1,285 KRW
−47.47 B KRW
14.30 B KRW
19.04 M
About GENOME&COMPANY
Sector
Headquarters
Seongnam-si
Founded
2015
Website
ISIN
KR7314130006
FIGI
BBG00MV6YMQ9
Genome & Co. engages in research and development of dietary supplements, cosmeceuticals, and new drugs utilizing human microbiome. The company was founded by Ji-Soo Bae and Han-Su Park on September 24, 2015 and is headquartered in Seongnam-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 314130 is 2,665 KRW — it has decreased by −2.74% in the past 24 hours. Watch GENOME&COMPANY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENOME&COMPANY stocks are traded under the ticker 314130.
314130 stock has fallen by −4.14% compared to the previous week, the month change is a −2.38% fall, over the last year GENOME&COMPANY has showed a −54.83% decrease.
314130 reached its all-time high on Dec 23, 2020 with the price of 47,500 KRW, and its all-time low was 2,470 KRW and was reached on Dec 9, 2024. View more price dynamics on 314130 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
314130 stock is 5.29% volatile and has beta coefficient of 0.95. Track GENOME&COMPANY stock price on the chart and check out the list of the most volatile stocks — is GENOME&COMPANY there?
Today GENOME&COMPANY has the market capitalization of 82.57 B, it has increased by 1.61% over the last week.
Yes, you can track GENOME&COMPANY financials in yearly and quarterly reports right on TradingView.
314130 net income for the last quarter is −6.79 B KRW, while the quarter before that showed 1.59 B KRW of net income which accounts for −525.84% change. Track more GENOME&COMPANY financial stats to get the full picture.
No, 314130 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 99.00 employees. See our rating of the largest employees — is GENOME&COMPANY on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOME&COMPANY EBITDA is −32.13 B KRW, and current EBITDA margin is −335.59%. See more stats in GENOME&COMPANY financial statements.
Like other stocks, 314130 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOME&COMPANY stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOME&COMPANY technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOME&COMPANY stock shows the sell signal. See more of GENOME&COMPANY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.